Key facts
- This page summarizes Robert W. Duggan's Form 4 filing for Summit Therapeutics Inc. (SMMT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Apr 2025, 17:12.
Robert W. Duggan - 08 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)
- Reporting relationship
- Co-Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- SMMT
- Reported as of
- 08 Apr 2025
- Net transaction value
- +$6,296,387
- SEC form
- 4
- Accepted by SEC
- 09 Apr 2025, 17:12:06 UTC
- Prior SEC filing
- 06 Jan 2025
- Next SEC filing
- 01 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert W. Duggan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert W. Duggan filed Form 4 for Summit Therapeutics Inc. (SMMT) on 09 Apr 2025.
Change
- Previous filing in this sequence was filed on 06 Jan 2025.
- Current net transaction value: +$6,296,387.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SMMT
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $6,296,387
- Shares
- +3,985,055
- Change %
- +0.72%
- Price
- $1.58
- Shares after
- 555,680,151
- Date
- 08 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
SMMT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 31,000
- Date
- 08 Apr 2025
- Ownership
- By Spouse
- Footnotes
- F2
SMMT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,199,776
- Date
- 08 Apr 2025
- Ownership
- By the Shaun Zanganeh Irrevocable Trust, with the Spouse of Reporting Person as Trustee
- Footnotes
- F2
SMMT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,457,666
- Date
- 08 Apr 2025
- Ownership
- By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee
- Footnotes
- F2
SMMT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 08 Apr 2025
- Ownership
- Immediate family member of Spouse
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SMMT
transaction
Derivative
Warrant (right to buy)
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- +3,985,055
- Change %
- Price
- $0.000000
- Shares after
- 0
- Date
- 08 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,985,055
- Exercise price
- $1.58
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On April 8, 2025, the Reporting Person exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share.
Footnote F2
The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.